---
document_datetime: 2026-01-20 09:41:30
document_pages: 4
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/evrysdi-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: evrysdi-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 2.4764024
conversion_datetime: 2026-01-20 20:13:36.583795
docling_version:
  docling-serve: 1.10.0
  docling-jobkit: 1.8.1
  docling: 2.69.0
  docling-core: 2.60.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.3
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Evrysdi

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency`s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessment history' section. For the complete product lifecycle procedures, you may need to also refer to EPAR - Procedural steps taken and scientific information after authorisation (archive) .

| Application number                    | Scope                                                                                                                          | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|---------------------------------------|--------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| Variation type IA / EMA/VR/0000313401 | B.II.b.3 Change in the manufacturing process of the finished product, including an intermediate used in the manufacture of the | 20/11/2025                          | N/A                                         |                                  |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|                                       | finished product - B.II.b.3.a Minor change in the manufacturing process - Accepted                                                                                                                                                                                                                                                                                                                                                                                 |            |            |                        |                                                                                                                                                                                                                                                                                                           |
|---------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Renewal - 5 year / EMA/R/0000275338   | - Renewal - Accepted                                                                                                                                                                                                                                                                                                                                                                                                                                               | 13/11/2025 | 08/01/2026 | SmPC, Annex II and PL  | Renewal of marketing authorisation. Based on the review of data on quality, safety and efficacy, the CHMP considered that the benefit-risk balance of Evrysdi in the approved indication remains favourable and therefore recommended the renewal of the marketing authorisation with unlimited validity. |
| Variation type II / EMA/VR/0000287985 | C.I HUMAN AND VETERINARY MEDICINAL PRODUCTS - C.I.13 Submission of additional clinical and non-clinical studies, including BE-studies. - Accepted Submission of the final report from study BP39054 (JEWELFISH) listed as a category 3 study in the RMP. This is an open-label phase 2 study to investigate the safety, tolerability, and pharmacokinetics/pharmacodynamics of risdiplam (RO7034067) in adult and pediatric patients with spinal muscular atrophy. | 09/10/2025 | N/A        |                        |                                                                                                                                                                                                                                                                                                           |
| Variation type IB / EMA/VR/0000293709 | B.II.f.1 Change in the shelf-life or storage conditions of the finished product - B.II.f.1.d Change in storage conditions of the finished product or the diluted/reconstituted product - Accepted                                                                                                                                                                                                                                                                  | 26/09/2025 | 08/01/2026 | SmPC, Labelling and PL |                                                                                                                                                                                                                                                                                                           |

<div style=\"page-break-after: always\"></div>

| Article 61(3) /                       | - Notification acc. Article 61(3) - Accepted Update of the Annex IIIA to include the update to section 16 of the labelling to reflect accurate information in Braille, an amendment to section 2 regarding composition and packaging details, and a revision to Section 5 of the package leaflet to align the storage requirements.                                                                                                                                                                                       | 26/06/2025   | 08/01/2026   | Labelling and PL   | EMA/N/0000281001   |
|---------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|--------------------|--------------------|
| Variation type IA / EMA/VR/0000280817 | A. ADMINISTRATIVE CHANGES - A.4 Change in the name and/or address of: a manufacturer (including where relevant quality control testing sites); or an ASMF holder; or a supplier of the active substance, starting material, reagent or intermediate used in the manufacture of the active substance (where specified in the technical dossier) where no Ph. Eur. Certificate of Suitability is part of the approved dossier; or a manufacturer of a novel excipient (where specified in the technical dossier) - Accepted | 23/06/2025   | N/A          |                    |                    |
| Variation type IA / EMA/VR/0000269671 | B.II.e.6 Change in any part of the (primary) packaging material not in contact with the finished product formulation (such as colour of flip-off caps, colour code rings on ampoules, change of needle shield (different plastic used)) - B.II.e.6.b Change that does not affect the product information - Accepted                                                                                                                                                                                                       | 16/05/2025   | N/A          |                    |                    |

<div style=\"page-break-after: always\"></div>

| PSUR / EMA/PSUR/0000268972   | - -   | Maintenance   |
|------------------------------|-------|---------------|